Genitourinary Cancer

Top Story

Less sleep, frequent snoring shorten breast cancer survival

Less sleep, frequent snoring shorten breast cancer survival
July 1, 2016

Short sleep duration and frequent snoring prior to cancer diagnosis may shorten OS among postmenopausal women with breast cancer.

Amanda I. Phipps , MPH, PhD, assistant professor of epidemiology at University of Washington, and colleagues assessed the association between sleep characteristics prior to cancer diagnosis and subsequent cancer survival among postmenopausal women who participated in the Women’s Health Initiative.

In the Journals

Rates of cytoreductive nephrectomy appear stable in targeted therapy era

June 30, 2016
Thirty-five percent of patients who received targeted therapy for renal cell carcinoma underwent cytoreductive nephrectomy, according to the results of retrospective…
Video

VIDEO: Novel therapies show promise for patients with bladder, kidney cancer

June 29, 2016
In this video, Russell K. Pachynski, MD, assistant professor at Washington University School of Medicine in St. Louis, discusses the results of updated efficacy data…
Meeting News Coverage

Biden: A decade’s worth of cancer research possible in half the time

June 29, 2016
PHILADELPHIA — Fox Chase Cancer Center today hosted a Regional Cancer Moonshot Summit in conjunction with the National Cancer Moonshot Summit held in Washington…
CME

The Patient with Myelofibrosis

No commercial support for this activity.

Myelofibrosis is caused by abnormal stem cells in the bone marrow that cause the uncontrolled production of mature…
More »
Video
Meeting News Coverage

VIDEO: Liquid biopsy technology a ‘major advance’ but still requires validation

May 5, 2016
More »
Featured
2016 ASCO Annual Meeting

2016 ASCO Annual Meeting

CME

The Patient with Castration-resistant Prostate Cancer

No commercial support for this activity.

Castration-resistant prostate cancer (CRPC) is a heterogeneous condition that encompasses a continuum of disease…
More »

Less sleep, frequent snoring shorten breast cancer survival

July 1, 2016
Short sleep duration and frequent snoring prior to cancer diagnosis may shorten OS among postmenopausal women with breast cancer. Amanda I

In the Journals

Rates of cytoreductive nephrectomy appear stable in targeted therapy era

June 30, 2016
Thirty-five percent of patients who received targeted therapy for renal cell carcinoma underwent cytoreductive nephrectomy, according to the results…

Video

VIDEO: Novel therapies show promise for patients with bladder, kidney cancer

June 29, 2016
In this video, Russell K. Pachynski, MD, assistant professor at Washington University School of Medicine in St. Louis, discusses the results of…

Meeting News Coverage

Biden: A decade’s worth of cancer research possible in half the time

June 29, 2016
PHILADELPHIA — Fox Chase Cancer Center today hosted a Regional Cancer Moonshot Summit in conjunction with the National Cancer Moonshot Summit…

AACR president: ‘Full spectrum’ of cancer research must remain priority

June 29, 2016
Nancy E. Davidson, MD, director of University of Pittsburgh Cancer Institute, took over as president of the American Association for Cancer Research…

FDA’s cancer drug director to lead Oncology Center of Excellence

June 29, 2016
Richard Pazdur, MD, director of the Office of Hematology and Oncology Products in the FDA’s Center for Drug Evaluation, has been named acting…

Ipilimumab, nivolumab linked with increased risk of autoimmune joint, tissue diseases in cancer patients

June 28, 2016
Patients with cancer treated with ipilimumab or nivolumab alone or in combination with each other experienced a higher than normal risk of developing…

Eight updates about how lifestyle affects cancer risk, outcomes

June 27, 2016
Lifestyle choices can contribute considerably to a person’s cancer risk, as well the outcomes they achieve after they are diagnosed with a…

FDA News

FDA grants Opdivo breakthrough therapy designation for advanced bladder cancer

June 27, 2016
The FDA granted breakthrough therapy designation to nivolumab for patients with unresectable locally advanced or metastatic urothelial carcinoma that…

At IssueVideo

VIDEO: Toxicities related to immune therapies ‘unpredictable’ but ‘manageable’

June 23, 2016
James P. Allison, PhD, chair of the department of immunology and executive director of the immunotherapy platform at MD Anderson Cancer Center in…

More Headlines »
morganatic-roan